Health Care·Health Care Equipment·$32.0B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.64 | N/A | +0.74% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $1.64 | N/A | +0.74% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management expressed confidence in their product pipeline while acknowledging external challenges. They are committed to navigating the current market environment.
Management highlighted ongoing demand for their products.
They noted challenges in supply chain but remain focused on innovation.
ResMed's earnings report showed a positive surprise on EPS, indicating better-than-expected profitability. However, the stock declined by 1.26% following the announcement, likely due to the absence of revenue figures and guidance. Investors may be cautious given the lack of detailed outlook and ongoing market challenges.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
BERKLEY W R CORP
Oct 23, 2023